PCK ASX · Health Care

Painchek Ltd

Announcements, last 12 months: 59
Price sensitive, last 12 months: 17
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Upcoming events

Wed 4 Nov 2026, 3:00 PM AEDT

PCK AGM

Latest announcements

Released	Headline	Actions
2 Nov 2026, 12:47 PM	PCK AGM watching the live feed
30 Oct 2026, 3:23 PM	Final Director's Interest Notice
28 Oct 2026, 12:48 PM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
27 Oct 2026, 9:12 AM	PainChek wins 1,800-licence UK contract with Hallmark Price sensitive	AI summary
26 Oct 2026, 9:05 AM	John Murray retires as PainChek non-executive director
13 Oct 2026, 12:50 PM	Notification regarding unquoted securities - PCK
13 Oct 2026, 9:09 AM	PainChek expands Sabra contracts to 23 US communities Price sensitive	AI summary
30 Sep 2026, 3:41 PM	Change of Director's Interest Notice x3
30 Sep 2026, 3:36 PM	Application for quotation of securities - PCK
30 Sep 2026, 12:25 PM	Notice of Annual General Meeting/Proxy Form

Sign in to see all PCK announcements.

Guidance history

13 Oct 2026	PainChek aims to convert 808 memory care licenses into implemented annual recurring revenue (ARR) by 31 December 2026.
30 Apr 2026	The company expects to see further traction across its numerous market opportunities through the rest of the year, with the Sabra agreement providing access to up to 36,000 beds across 329 facilities, of which 20,000 (ARR $2M) are applicable to PainChek.
27 Feb 2026	The company expects to obtain a Research & Development Tax incentive refund by 31 May 2026 for the year to 30 June 2025.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow PCK to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.